The first drug prescribed to most people with Type 2 diabetes is typically metformin—but for a broad range of reasons, many patients can’t tolerate the drug.
Researchers seeking effective alternatives are looking at a class of older antipsychotic drugs. They found that these drugs can target an enzyme linked to reducing blood sugar.
